Small
Normal
Large
2013.05.16
PDF/61KB
Dainippon Sumitomo Pharma announces BBI608 Clinical Study Data to be presented at the 2013 ASCO Annual Meeting
2013.05.09
PDF/41KB
Dainippon Sumitomo Pharma announces BBI608 Phase 1 Clinical Study Data to be presented at the 2013 ASCO Annual Meeting
2013.05.09
PDF/357KB
Presentation Material (Financial Results for FY2012)
2013.05.09
PDF/229KB
Supplementary Financial Data for the Year Ended March 31, 2013
2013.05.09
PDF/505KB
Summary of Consolidated Financial Results for the Year Ended March 31, 2013 [Japanese GAAP] (Unaudited)
2013.05.09
PDF/66KB
Change of Directors and Audit & Supervisory Board Members
A Message from the President
Corporate Philosophy
Corporate Governance
Compliance
Risk Management
Corporate History
Corporate Profile
Business Units
Pharmaceutical Business
Other Products
Board of Directors and Executive Officers
Organizational Chart